Structural Heart Devices Market

The report "Structural Heart Devices Market by Product (Heart Valve Devices Transcatheter and Surgical), Occluders, Closure and Delivery Systems, Annuloplasty Rings, Accessories, Procedure (Replacement(TAVR/TAVI), Repair & End-Users - Global Forecast to 2029", is valued at an estimated 16.31 billion in 2024 and is projected to reach USD 25.69 billion by 2029, at a CAGR of 9.5% during the forecast period.

Browse 359 market data Tables and 53 Figures spread through 304 Pages and in-depth TOC on "Structural Heart Devices Market by Product (Heart Valve Devices Transcatheter and Surgical), Occluders, Closure and Delivery Systems, Annuloplasty Rings, Accessories, Procedure (Replacement(TAVR/TAVI), Repair & End-Users - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/structural-heart-device-market-161123753.html

Structural heart devices market growth drivers include several key factors. The growth of the structural heart devices market is driven by several key factors. Firstly, the rising prevalence of valvular and congenital heart diseases, particularly among aging populations, has significantly increased the demand for advanced treatment options. Secondly, technological advancements in minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair/replacement (TMVR), offer safer alternatives to traditional open-heart surgeries, enhancing patient adoption. Thirdly, expanding reimbursement frameworks and improved healthcare infrastructure in developed and emerging markets have made these devices more accessible. Fourth, the growing awareness among physicians and patients about the benefits of early intervention and minimally invasive therapies has accelerated adoption rates. Lastly, the continuous innovation by leading companies, including the development of next-generation devices with enhanced durability, precision, and ease of use, further fuels market expansion. Together, these factors create a robust growth trajectory for the structural heart devices market globally.

In addition, favorably undertaken reimbursement policies, particularly in developed regions, including the U.S. and Europe, increase the sale of these advanced devices among hospitals and other healthcare service-providing facilities. The investments being made in the infrastructures of health care and the increasing interventional procedures across the world, especially in emerging markets, are also multiplying the growth of the market. Finally, the increase in healthcare expenditures along with strategies for reducing the number of amputations, coupled with early interventions, have furthered the growth of demand?

“By Product, Heart Valve devices  hold the largest share in 2023.”

Transcatheter heart valve devices are driving the structural heart business because they have drastically shifted the treatment modalities for valvular heart disease, most importantly aortic stenosis and mitral regurgitation. TAVR and TMVR have been a minimally invasive alternative for the patients who fall into the high risk or are otherwise inoperable. Although extensive use by both healthcare providers and patients has occurred due to shortened recovery times, decreased complication rates, and improvement of patient outcomes, advances in valve durability, sealing, and delivery improve clinical efficacy and broaden applications. It has also improved access due to heightened awareness and expanding reimbursement policies. Transcatheter heart valve devices are expected to impel market growth in the structural heart market with an increasing elderly population and rising cases of more valvular diseases.

“North America dominates the global Structural heart devices marketin 2023.”

The Structural heart devices market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2023 North America accounted for the largest share during the forecast period.The key factors driving the large share of North America in the Structural heart devices market can be attributed to improved healthcare infrastructure, accessibility to advanced technologies, and highly professional practitioners.  Increasing numbers of patients in North America, especially in the U.S., undergo surgical procedures including repair/replacement of valves. Medicare and private insurance offer positive reimbursement policies that enhance the use of these devices. The major medical equipment manufacturers of firms like Edwards Lifesciences Corporation, Medtronic, Abbott, and Boston Scientific are headquartered in this region, so there is emerging innovation as well as extensive availability of superior vascular devices?

The few strong players in this market are Edwards Lifesciences Corporation (U.S), Boston Scientific Corporation (U.S.), Medtronic ( U.S), Philips(Japan), Merit Medical Systems (U.S.), Abbott (U.S.), and Terumo Corporation (Japan) among others.Edwards Lifesciences Corporation (U.S),  Medtronic (Ireland) , Boston Scientific Corporation (U.S), Abbott (U.S) , Teleflex (U.S), Integer Holdings Corporation(U.S) , Lepu Medical Technology Co.Ltd.(China), TTK (India) ,Artivion, Inc. (U.S), Venus Medtech, Inc.(China),Cook(U.S),SMT (India), Meril Lifesciences Pvt.Ltd (India), W.L Gore & Associates,Inc. (U.S),Cordis (U.S), Foldax (U.S), Micro Interventional Devices, Incorporated (U.S), Cardiac Dimensions (U.S), HighLife Medical (France), Mitralign (U.S), Braile Biomedica (Brazil), JenaValve (Germany), Corcym (Italy), Xeltis (Switzerland) and Innovheart SRL (U.S) among others.

Don’t miss out on business opportunities in Structural Heart Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]